Results 91 to 100 of about 762,366 (142)

CT imaging features as predictors of homologous recombination deficiency and prognosis in high-grade serous ovarian cancer. [PDF]

Abdom Radiol (NY)
Kojo S, Takada A, Yokota H, Otsuka S, Matsuoka A, Nishikimi K, Tate S, Yoshida H, Sugawara H, Namba S, Horikoshi T, Nasu K, Uno T.   +12 more
europepmc   +1 more source

Treatment for metastatic triple-negative breast cancer with homologous recombination deficiency: a Bayesian network meta-analysis. [PDF]

BMC Cancer
Xu H, Wang Y, Sa Q, Zhou Y, Wang J, Xu B.   +5 more
europepmc   +1 more source

Performance Assessment of a Locally Semi-Automated NGS-Based Workflow for Homologous Recombination Deficiency Testing in High-Grade Serous Ovarian Carcinoma. [PDF]

Biomedicines
Colomar-Roig M, Navarro L, Megías J, Núñez-Abad M, Roselló-Sastre E, Santonja-López N, San-Miguel T.   +6 more
europepmc   +1 more source

Homologous recombination deficiency correlates with tumor-infiltrating lymphocytes and predicts patient outcomes in hormone receptor-positive/HER2-negative breast cancer. [PDF]

Ther Adv Med Oncol
Zhang SJ, Fu JF, Li CC, Wang L, Zhao X, Zhu XY, Qian ZL, Sun WY, Zheng LF, Chen XY, Lu X, Cao WM.   +11 more
europepmc   +1 more source

Homologous Recombination Deficiency in Skin Cancers: Prevalence and Clinical Implications of This Distinct Patient Cohort. [PDF]

JCO Precis Oncol
Nassief G, Adeyelu T, Elliott A, Phillipps J, Morecroft R, Zhou AY, Szlosarek PW, Robert C, Abdulla F, Vanderwalde A, Park SJ, Chen D, Ansstas G.   +12 more
europepmc   +1 more source

Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer: A Narrative Review. [PDF]

Ann Surg Oncol
Liguori L, Ventin M, Cattaneo G, Zhang L, Osipov A, Sabbatino F, Ferrone CR.   +6 more
europepmc   +1 more source

Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort. [PDF]

Commun Med (Lond)
Al Assaad M, Hadi K, Levine MF, Guevara D, Patel M, Tranquille M, King A, Otilano J, Semaan A, Gundem G, Medina-Martínez JS, Sigouros M, Manohar J, Kuo HH, Wilkes DC, Andreopoulou E, Chapman-Davis E, Tagawa ST, Sboner A, Ocean AJ, Shah MA, Papaemmanuil E, Sternberg CN, Holcomb K, Nanus DM, Elemento O, Mosquera JM.   +26 more
europepmc   +1 more source

Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification. [PDF]

EBioMedicine
Fortuno C, Zhang J, Koufariotis LT, Hollway G, Wood S, Pearson JV, Simpson PT, Lakhani SR, McCart Reed AE, Thorne H, Mann GB, Skandarajah AR, Devereux L, Zhao Q, De Silva DL, Lindeman GJ, Waring P, James PA, Campbell I, Spurdle AB, Waddell N.   +20 more
europepmc   +1 more source

RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer. [PDF]

NPJ Breast Cancer
Llop-Guevara A, Pellegrino B, Pimentel I, Villacampa G, Solinas C, Torres-Esquius S, Campanini N, Simonetti S, Tommasi C, Serra O, Corianò M, Boggiani D, Michiara M, Minari R, Bortesi B, Rapacchi E, Dieci MV, Lambertini M, Zoppoli G, Schirone A, Casarini C, Cretella E, Cortesi L, Silini EM, Saura C, Willard-Gallo K, Boisson A, Musolino A, Serra V, Balmaña J, Cruz C.   +30 more
europepmc   +1 more source

Homologous Recombination Deficiency and Survival in Ovarian High-Grade Serous Carcinoma by Self-Reported Race. [PDF]

Cancer Epidemiol Biomarkers Prev
Lawson-Michod KA, Johnson CE, Barnard ME, Davidson NR, Collin LJ, Nix DA, Huff CD, Berchuck A, Salas LA, Greene CS, Marks JR, Peres LC, Doherty JA, Schildkraut JM.   +13 more
europepmc   +1 more source